These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9708742)

  • 1. Peddling drugs to the pedal pushers.
    Lancet; 1998 Aug; 352(9126):415. PubMed ID: 9708742
    [No Abstract]   [Full Text] [Related]  

  • 2. World-class cyclists on erythropoietin.
    Heuberger JA; Cohen AF
    Br J Clin Pharmacol; 2014 Mar; 77(3):582. PubMed ID: 23772931
    [No Abstract]   [Full Text] [Related]  

  • 3. DOPING. Cyclists' favorite drug falls flat in trial.
    Enserink M
    Science; 2016 Jul; 353(6296):206-7. PubMed ID: 27418482
    [No Abstract]   [Full Text] [Related]  

  • 4. Little soldiers in their cardboard cells.
    van Breda E; Benders J; Kuipers H
    Br J Clin Pharmacol; 2014 Mar; 77(3):580-1. PubMed ID: 23772979
    [No Abstract]   [Full Text] [Related]  

  • 5. Police find range of drugs after trawling bins used by Tour de France cyclists.
    Benkimoun P
    BMJ; 2009 Oct; 339():b4201. PubMed ID: 19825964
    [No Abstract]   [Full Text] [Related]  

  • 6. What is a normal red-blood cell mass for professional cyclists?
    Saris WH; Senden JM; Brouns F
    Lancet; 1998 Nov; 352(9142):1758. PubMed ID: 9848362
    [No Abstract]   [Full Text] [Related]  

  • 7. Some empirical notes on the epo epidemic in professional cycling.
    Lodewijkx HF; Brouwer B
    Res Q Exerc Sport; 2011 Dec; 82(4):740-54. PubMed ID: 22276416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin on cycling performance.
    Sperlich B; Calbet JAL; Holmberg HC
    Lancet Haematol; 2017 Oct; 4(10):e462. PubMed ID: 28962680
    [No Abstract]   [Full Text] [Related]  

  • 9. Doping destroys the story at the heart of cycling.
    Riley S
    Nature; 2007 Sep; 449(7160):281. PubMed ID: 17882200
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit.
    Heuberger JA; Cohen Tervaert JM; Schepers FM; Vliegenthart AD; Rotmans JI; Daniels JM; Burggraaf J; Cohen AF
    Br J Clin Pharmacol; 2013 Jun; 75(6):1406-21. PubMed ID: 23216370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood doping: 2].
    Cristani A; Boldrini E; Amateis E; Arioli D
    Recenti Prog Med; 2005 Jan; 96(1):1-3. PubMed ID: 15789630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tour de Farce.
    Jarvis CA
    Br J Sports Med; 1999 Apr; 33(2):142-3. PubMed ID: 10205712
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of drugs to improve athletic performance].
    Verheij TC
    Ned Tijdschr Geneeskd; 1997 Nov; 141(48):2364-5. PubMed ID: 9550839
    [No Abstract]   [Full Text] [Related]  

  • 14. [Putative effects of doping in cycling].
    Kuipers H
    Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2643-5. PubMed ID: 17205940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switch off the light on cycling, switch off the light on doping.
    Lippi G; Franchini M; Cesare Guidi G
    Br J Sports Med; 2008 Mar; 42(3):162. PubMed ID: 17984192
    [No Abstract]   [Full Text] [Related]  

  • 16. All doped up--and going for the gold.
    Zorpette G
    Sci Am; 2000 May; 282(5):20, 22. PubMed ID: 11056980
    [No Abstract]   [Full Text] [Related]  

  • 17. [Point of view on doping].
    Naeije R; Pagnamenta A
    Rev Med Brux; 1999 Jun; 20(3):153-8. PubMed ID: 10429539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What illegal substances are used by sportsmen? a study in Midi-Pyrénées Doping Preventing Medical Centre (AMPD-MP)].
    Senard-Ojero A; Durrieu G; Depiesse F; Schmitt L; Riviere D; Montastruc JL
    Therapie; 2010; 65(5):459-63. PubMed ID: 21144481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From testing the champions to championing the locals.
    Aislabie J
    BMJ; 2013 Sep; 347():f5528. PubMed ID: 24030566
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of exercise on serum markers of altered erythropoiesis and the indirect detection models of recombinant human erythropoietin abuse in athletes.
    Schumacher YO; Temme J; Bueltermann D; Schmid A; Berg A
    Haematologica; 2003 Jun; 88(6):712-4. PubMed ID: 12801849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.